Due to its innate flexibility and its ability to exploit an ever-expanding number of chemical and physical properties used for molecular separation, the future for the U.S. liquid chromatography markets is very promising. The adoption of this separations methodology for a growing variety of applications in the life sciences industry, especially in non-research areas, such as, drug manufacturing and production, is likely to account for much of the future growth of this market.
“The need to separate small molecule compounds and biomolecules for research and commercial purposes has prompted users to look to liquid chromatography as a reliable method for analytical separation of complex mixtures,” notes Frost & Sullivan Research Analyst Shankar Sellappan, Ph.D. “The market outlook is very positive for liquid chromatography products through 2013, as investments in this approach continue to be made.”
New analysis from Frost & Sullivan (drugdiscovery.frost.com), U.S. Liquid Chromatography Markets, finds that these markets earned revenues of $596.3 million in 2006 and estimates this to reach $1.018 billion in 2013.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the U.S. Liquid Chromatography Markets, then send an email to Melina Trevino - Corporate Communications at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, email address, city, state, and country. We will send you the information via email upon receipt of the above information.
Liquid chromatography has been steadily progressing from a strictly research tool to one that is increasingly used for drug manufacturing applications and quality assessment of pharmaceutical products. This has created demand for instruments of higher resolution power that can handle larger volumes of samples and lend themselves to constant use. There has also been concomitant growth experienced by market participants that provide columns, resins, and other consumables needed in liquid chromatography for separating analytes.
Going forward, a major challenge that could restrict continued growth of the liquid chromatography market is the need for constant innovation of these product classes to expand their capabilities and that create opportunities in newer applications. Sustaining the level of technological innovation that has created so many new users and driven strong market growth is bound to be a difficult task.
“One of the reasons why liquid chromatography is so sought after as a separations methodology is that it provides a greater level of efficiency in the processing of high volumes of samples,” explains Dr. Sellappan. “Resin particles that are less than two microns in size offer significant efficiency and cost benefits, but manufacturing these smaller particles as well as ensuring their quality and homogeneity are a considerable challenge.”
The emergence of pharmaceutical manufacturing facilities outside the United States in locations such as Puerto Rico and India may also affect the overall demand for liquid chromatography products in the United States.
However, the shift in the end-user base for this technology is a significant development that continues to contribute strongly to its growth prospects, as does the need to produce drugs quickly, inexpensively, and uniformly. There is still a lack of competing technologies that can achieve such levels of separation, driving users to continue using liquid chromatography for their separation needs, whether for research or commercial applications.
“The flexibility of liquid chromatography is a testament to the industry for developing products that can be exploited for analytical separation,” states Dr. Sellappan. “Although the liquid chromatography market is led by a few major participants, opportunities for smaller companies do exist and the needs of different types of end users will continue to drive participation from new companies.”
U.S. Liquid Chromatography Markets, part of the Drug Discovery & Clinical Diagnostics Growth Partnership Service, provides a comprehensive overview of the systems and consumable products used in liquid chromatography applications. It identifies market drivers and restraints, technology and market trends, applications that employ liquid chromatography, competitive technologies, as well as challenges to market growth. This study also provides revenue forecasts and market share analysis for individual market segments and for the overall liquid chromatography market. Interviews with the press are available.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective, and combines ongoing analysis of markets, technologies, econometrics, and demographics.